The human digestive tract contains trillions of microorganisms that constantly compete for space and nutrients. This system can be highly susceptible to attacks from harmful bacteria, which can result in digestive discomfort and a weakened immune system. It is therefore important for beneficial bacteria to outperform these harmful bacteria so that proper intestinal balance and overall good health can be achieved. Unfortunately the opposite can sometimes occur, in which aggressive strains of harmful bacteria outgrow and consume more resources than the beneficial bacteria. This phenomenon can be associated with poor health, abdominal discomfort, and bacterial infections. To combat these intestinal imbalances and their damaging effects, Floraphage has been developed to support the restoration and maintenance of the highly sensitive digestive ecosystem.
Floraphage was designed to support the proliferation of beneficial bacteria throughout the gastrointestinal tract in order to promote optimal digestive and immune health. Floraphage was tested in conjunction with four popular probiotic supplements to determine its ability to increase the potency or growth of each respective product. The average increase in CFU activity, which is the measurement of probiotic bacteria growth, for the four products was 2400% versus control (growth without the use of Floraphage). Floraphage is an excellent product to take in conjunction with a probiotic to maximize the benefits of supplemented beneficial bacteria. It is also helpful for those who do not take probiotics in order to maximize indigenous bacteria growth.
*Floraphage and Beneficial Bacteria
Floraphage was able to increase the growth rate of supplemented probiotics by an average of 24x compared to control.*
*Each product was grown in a nutrient-rich broth to mimic normal digestive conditions, until each products bacteria reached a specified value using optical density (OD). OD measures the amount of light that is able to scatter through a mixture, and was simply used to verify that the bacteria for each product had started to divide (grow). Once each product reached an OD of .2 (that simply indicated that the bacteria were growing and no longer dormant), a one milliliter sampling of each product was grown with Floraphage and without (control). Each of the four tested products showed improvement when grown with Floraphage. 1 Jarro-Dophilus EPS is a registered trademark of Jarrow Formulas, Inc. and has no affiliation with Arthur Andrew Medical. 2 Dr. Ohhira’s Probiotics is a registered trademark of Essential Formulas, Inc. and has no affiliation with Arthur Andrew Medical. 3 PB 8 is a registered trademark of Nutrition Now, Inc. and has no affiliation with Arthur Andrew Medical.